Signature Estate & Investment Advisors LLC Buys New Position in Entera Bio Ltd. (NASDAQ:ENTX)

Signature Estate & Investment Advisors LLC purchased a new position in Entera Bio Ltd. (NASDAQ:ENTX) during the 3rd quarter, HoldingsChannel reports. The firm purchased 47,328 shares of the company’s stock, valued at approximately $90,000.

Separately, Virtu Financial LLC acquired a new position in shares of Entera Bio in the 1st quarter worth approximately $37,000. 14.11% of the stock is owned by institutional investors and hedge funds.

Entera Bio Stock Down 2.8 %

Shares of NASDAQ ENTX opened at $1.73 on Monday. The stock’s fifty day simple moving average is $1.85 and its 200 day simple moving average is $1.91. The stock has a market capitalization of $61.91 million, a price-to-earnings ratio of -6.65 and a beta of 1.58. Entera Bio Ltd. has a 52-week low of $0.52 and a 52-week high of $3.35.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and set a $10.00 target price on shares of Entera Bio in a report on Monday, November 11th.

Entera Bio Profile

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures.